China SXT Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $36.5K | $9.4M | $7.3M |
| FY2021 | $6.3K | $16.0M | $13.4M |
| FY2022 | — | $16.1M | $15.6M |
| FY2023 | $117.9K | $14.7M | $17.4M |
| FY2024 | $117.1K | $13.9M | $12.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $36.5K | $9.4M | $7.3M |
| FY2021 | $6.3K | $16.0M | $13.4M |
| FY2022 | — | $16.1M | $15.6M |
| FY2023 | $117.9K | $14.7M | $17.4M |
| FY2024 | $117.1K | $13.9M | $12.1M |